1-5 of 5
Alice Krol
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Acarbose in Insulin-Treated Patients With Type 2 Diabetes

David E Kelley, MD, Pascual Bidot, MD, Zachary Freedman, MD, Burritt Haag, MD, David Podlecki, MD, Marc Rendell, MD, David Schimel, MD, Stuart Weiss, MD, Terry Taylor, MD, Alice Krol, MS, James Magner, MS
Journal: Diabetes Care
Diabetes Care 1998;21(12):2056–2061
https://doi.org/10.2337/diacare.21.12.2056
Published: 01 December 1998
View articletitled, Efficacy and Safety of Acarbose in Insulin-Treated Patients With Type 2 Diabetes
Open the PDF for Efficacy and Safety of Acarbose in Insulin-Treated Patients With Type 2 Diabetes in another window
Journal Articles

Efficacy and Safety of Acarbose in Metformin-Treated Patients With Type 2 Diabetes

Julio Rosenstock, MD, Ann Brown, MD, Jerome Fischer, MD, Adesh Jain, MD, Thomas Littlejohn, MD, Dan Nadeau, MD, Allen Sussman, MD, Terry Taylor, MD, Alice Krol, MS, James Magner, MD
Journal: Diabetes Care
Diabetes Care 1998;21(12):2050–2055
https://doi.org/10.2337/diacare.21.12.2050
Published: 01 December 1998
View articletitled, Efficacy and Safety of Acarbose in Metformin-Treated Patients With Type 2 Diabetes
Open the PDF for Efficacy and Safety of Acarbose in Metformin-Treated Patients With Type 2 Diabetes in another window
Journal Articles

Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients

Peter S Johnston, MD, Peter U Feig, MD, Robert F Coniff, MD, Alice Krol, MS, Jaime A Davidson, MD, Steven M Haffner, MD
Journal: Diabetes Care
Diabetes Care 1998;21(3):409–415
https://doi.org/10.2337/diacare.21.3.409
Published: 01 March 1998
View articletitled, Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients
Open the PDF for Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients in another window
Journal Articles

Chronic Treatment of African-American Type 2 Diabetic Patients With β-Glucosidase Inhibition

Peter S Johnston, MD, Peter U Feig, MD, Robert F Coniff, MD, Alice Krol, MS, David E Kelley, MD, Arshag D Mooradian, MD
Journal: Diabetes Care
Diabetes Care 1998;21(3):416–422
https://doi.org/10.2337/diacare.21.3.416
Published: 01 March 1998
View articletitled, Chronic Treatment of African-American Type 2 Diabetic Patients With β-Glucosidase Inhibition
Open the PDF for Chronic Treatment of African-American Type 2 Diabetic Patients With β-Glucosidase Inhibition in another window
Journal Articles

Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients

Peter S Johnston, MD, Robert F Coniff, MD, Byron J Hoogwerf, MD, Julio V Santiago, MD, F Xavier Pi-Sunyer, MD, Alice Krol
Journal: Diabetes Care
Diabetes Care 1994;17(1):20–29
https://doi.org/10.2337/diacare.17.1.20
Published: 01 January 1994
View articletitled, Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients
Open the PDF for Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients in another window